TransMedics (TMDX) Share-based Compensation (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.93% |
| Dec 31, 2025 | 2.83% |
| Sep 30, 2025 | -2.52% |
| Jun 30, 2025 | 4.62% |
| Mar 31, 2025 | -16.80% |
| Dec 31, 2024 | 35.54% |
| Sep 30, 2024 | 3.94% |
| Jun 30, 2024 | 11.25% |
| Mar 31, 2024 | 20.02% |
| Dec 31, 2023 | 10.33% |
| Sep 30, 2023 | 4.64% |
| Jun 30, 2023 | 26.45% |
| Mar 31, 2023 | 31.09% |
| Dec 31, 2022 | 10.61% |
| Sep 30, 2022 | 16.75% |
| Jun 30, 2022 | 0.26% |
| Mar 31, 2022 | 16.37% |
| Dec 31, 2021 | 0.61% |
| Sep 30, 2021 | 9.13% |
| Jun 30, 2021 | 62.59% |
| Mar 31, 2021 | 59.31% |
| Dec 31, 2020 | -0.29% |
| Sep 30, 2020 | 10.94% |
| Jun 30, 2020 | 63.90% |
| Mar 31, 2020 | 36.52% |
| Dec 28, 2019 | -4.41% |
| Sep 28, 2019 | 33.48% |
| Jun 29, 2019 | 287.72% |
| Mar 30, 2019 | 9.62% |
| Dec 29, 2018 | 67.74% |
| Sep 29, 2018 | -6.06% |
| Jun 30, 2018 | 22.22% |